Dental Soft Tissue Regeneration Market Summary
According to Market Research Future Reports analysis, the Dental Soft Tissue Regeneration Market size was valued at USD 1.756 Billion in 2024. The market is projected to grow from USD 1.847 Billion in 2025 to USD 3.055 Billion by 2035, registering a CAGR of 5.16% during the forecast 2025–2035. North America led the market with 46% share, generating around USD 0.8 billion in revenue.
Increasing prevalence of periodontal diseases and rising demand for aesthetic dental procedures are key growth drivers, supported by advancements in biomaterials and regenerative techniques, encouraging adoption of soft tissue regeneration solutions to improve oral health outcomes and patient satisfaction globally.
According to the World Health Organization (WHO), severe periodontal disease affects nearly 19% of the global adult population, representing over 1 billion cases worldwide, highlighting strong demand for advanced dental regeneration treatments and technologies to address growing oral health challenges effectively.
Key Market Trends & Highlights
The Dental Soft Tissue Regeneration Market is poised for substantial growth driven by technological advancements and increasing consumer demand.
- North America leads with 46% market share in 2024, driven by advanced dental infrastructure and high awareness of oral health.
- Europe accounts for 30% share, generating approximately USD 0.527 billion in 2024, supported by strong healthcare systems and research.
- Rising periodontal disease burden affecting over 1 billion people globally is significantly driving demand for soft tissue regeneration solutions.
- Gingival grafting dominates with 43% share in 2024, supported by strong clinical outcomes and increasing cosmetic dental procedures worldwide.
Market Size & Forecast
| 2024 Market Size | 1.756 (USD Billion) |
| 2035 Market Size | 3.055 (USD Billion) |
| CAGR (2025 - 2035) | 5.16% |
Major Players
Companies such as Straumann (CH), Dentsply Sirona (US), Zimmer Biomet (US), MediWound (IL), Acelity (US), KCI Medical (US), Hiossen (KR), Biomet 3i (US), Osstem Implant (KR) are some of the major participants in the global market.